Tuberculosis of nervous system
ICD-10 A17 is a used to indicate a diagnosis of tuberculosis of nervous system.
Tuberculosis of the nervous system is a serious and potentially life-threatening condition caused by the Mycobacterium tuberculosis bacteria. It can manifest in various forms, including tuberculous meningitis, tuberculomas, and spinal tuberculosis. The condition often arises from a primary pulmonary infection that disseminates to the central nervous system (CNS). Symptoms may include severe headaches, fever, altered mental status, seizures, and focal neurological deficits. Diagnosis typically involves a combination of clinical evaluation, imaging studies such as MRI or CT scans, and laboratory tests including cerebrospinal fluid (CSF) analysis, which may reveal elevated protein levels, lymphocytic pleocytosis, and the presence of acid-fast bacilli. Treatment usually requires a prolonged course of antitubercular medications, often including isoniazid, rifampicin, pyrazinamide, and ethambutol, with careful monitoring for drug resistance and side effects. Public health considerations are paramount, as tuberculosis is a communicable disease, necessitating contact tracing and isolation protocols to prevent transmission. Drug resistance is a significant concern, particularly in cases of multidrug-resistant tuberculosis (MDR-TB), which complicates treatment and increases morbidity and mortality rates.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with neurological symptoms and a history of tuberculosis.
Consideration of drug resistance and the need for multidisciplinary management.
Neurological examination findings, imaging results, and CSF analysis.
Patients with altered mental status or seizures with a known history of tuberculosis.
Coordination with infectious disease specialists for comprehensive care.
Used to obtain CSF for analysis in suspected cases of tuberculous meningitis.
Document indication for lumbar puncture and CSF findings.
Infectious disease specialists may need to interpret CSF results.
Common symptoms include severe headaches, fever, altered mental status, seizures, and focal neurological deficits.
Diagnosis typically involves clinical evaluation, imaging studies, and analysis of cerebrospinal fluid (CSF) for signs of infection.
Treatment usually involves a multi-drug regimen including isoniazid, rifampicin, pyrazinamide, and ethambutol, with careful monitoring for drug resistance.
